BIOGEN (DENMARK) A/S: Financial statements 2023
CVR: 21682977
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BIOGEN (DENMARK) A/S (CVR 21682977) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 259,564,233 and a net result of DKK 8,338,739 compared with DKK 8,438,232 the year before. That is a decrease of 15.6% compared with the year before. The profit margin was 3.2%. Equity in the 2023 report amounted to DKK 138,795,742. The solvency ratio was 69.9%. The company had 24 employees in the financial year.
- Revenue
- DKK 259,564,233
- Gross Profit
- DKK 44,226,917
- Profit/Loss
- DKK 8,338,739
- Equity
- DKK 138,795,742
- Total Assets
- DKK 198,577,798
- Employees
- 24
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 259.6 mio. | 44.2 mio. | 8.3 mio. | 138.8 mio. | 24 |
| 2022 | 307.5 mio. | 47 mio. | 8.4 mio. | 130.5 mio. | 24 |
| 2021 | 259.7 mio. | 45.9 mio. | 7.6 mio. | 122 mio. | 22 |
| 2020 | 303.4 mio. | 51.7 mio. | 10.1 mio. | 114.5 mio. | 25 |
| 2019 | 324.9 mio. | 49.6 mio. | 12.3 mio. | 104.3 mio. | 27 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 1, 2023, Morten Lofthus Tangnes has joined the board of directors of BIOGEN (DENMARK) A/S.
As of December 1, 2023, Louise Hammerich has left the board of directors of BIOGEN (DENMARK) A/S.
As of December 1, 2023, Morten Lofthus Tangnes is registered as director of BIOGEN (DENMARK) A/S.
As of December 1, 2023, Louise Hammerich has stepped down as adm. dir. of BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S has published its annual report for 2022. Revenue came to DKK 307,509,784, and the net result was DKK 8,438,232.
About BIOGEN (DENMARK) A/S
BIOGEN (DENMARK) A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1999. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BIOGEN IDEC (DENMARK) A/S. The management consists of Erik Magnus Bodin. The board consists of Neil Raymond Sisak (chair), Allan Frank Fischer Petersen, Erik Magnus Bodin and Sergio Ferreira da Silva Teixeira. The company is owned by Biogen Netherlands B.V.. The company has 13 employees (2026). In 2025, the company reported revenue of DKK 178,728,185 and a net result of DKK 5,563,672 compared with DKK 7,526,703 the year before. Equity in the 2025 report amounted to DKK 151,886,117.